Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma Journal Article
| Authors: | Barker, C. A.; Yahalom, J. |
| Article Title: | Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma |
| Keywords: | event free survival; treatment response; disease-free survival; histone deacetylase inhibitor; clinical trial; drug efficacy; antineoplastic agents; clinical trials as topic; note; cancer patient; disease free survival; rituximab; antineoplastic agent; letter; metabolism; enzyme inhibition; monoclonal antibody; cutaneous t cell lymphoma; antibodies, monoclonal; drug antagonism; nonhodgkin lymphoma; drug mechanism; lymphoma, non-hodgkin; vorinostat; histone deacetylase inhibitors; hydroxamic acids; cancer relapse; large cell lymphoma; hydroxymethylglutaryl coenzyme a reductase inhibitor; romidepsin; follicular lymphoma; lymphoma, follicular; drug interactions; hydroxamic acid; depsipeptides; histone deacetylase; depsipeptide; drug interaction; mocetinostat; phase 2 clinical trial (topic); hydroxymethylglutaryl-coa reductase inhibitors |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 24 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-08-20 |
| Start Page: | e426 |
| Language: | English |
| DOI: | 10.1200/jco.2010.28.9488 |
| PUBMED: | 20566995 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 20 April 2011" - "CODEN: JCOND" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work